Early research (Phase 1)Looking for participantsNCT06983743What this trial is testingERAS-0015 in Patients With Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid Tumors Erasca, Inc. 600
Testing effectiveness (Phase 2)UnknownNCT05842785What this trial is testingTSN222 in Subjects With Advanced Solid Tumors or LymphomasWho this might be right forHas a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Tyligand Bioscience (Shanghai) Limited 162
Testing effectiveness (Phase 2)Study completedNCT03098550What this trial is testingTest the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have SpreadWho this might be right forAdvanced Cancer Bristol-Myers Squibb 105
Early research (Phase 1)WithdrawnNCT04797468What this trial is testingThe CD73 Inhibitor(HLX23) Alone in Participants With Solid TumorWho this might be right forAdvanced Solid Tumor Shanghai Henlius Biotech
Early research (Phase 1)Ended earlyNCT01112397What this trial is testingStudy to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid TumoursWho this might be right forSolid Malignancies AstraZeneca 72
Early research (Phase 1)Study completedNCT05528120What this trial is testingFood Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult SubjectsWho this might be right forLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion Jiangsu vcare pharmaceutical technology co., LTD 16
Testing effectiveness (Phase 2)Study completedNCT06170190What this trial is testingA Multicentre,Study of IBI133 in Subjects WithUnresectable, Locally Advanced or Metastatic SolidTumoursWho this might be right forLocally Advanced Unresectable or Metastatic Solid Tumors Innovent Biologics (Suzhou) Co. Ltd. 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07272590What this trial is testingStudy of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid TumorsWho this might be right forMetastatic Solid Tumors Qilu Pharmaceutical Co., Ltd. 290
Early research (Phase 1)Ended earlyNCT04060342What this trial is testingGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Early research (Phase 1)Study completedNCT04291079What this trial is testingSRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)Who this might be right forCancer Scholar Rock, Inc. 112
Early research (Phase 1)Active Not RecruitingNCT02495896What this trial is testingRecombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more University of Southern California 61
Early research (Phase 1)Looking for participantsNCT06821048What this trial is testingStudy of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid TumorsWho this might be right forColorectal CancerStomach CancerPancreatic Cancer+1 more Weijia Fang, MD 18
Testing effectiveness (Phase 2)Looking for participantsNCT05118789What this trial is testingZidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)Who this might be right forLocally Advanced Solid TumorMetastatic Solid Tumor Nuvalent Inc. 359
Early research (Phase 1)Looking for participantsNCT05859074What this trial is testingMQ710 With and Without Pembrolizumab in People With Solid Tumor CancerWho this might be right forCutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT02401815What this trial is testingCGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid TumorsWho this might be right forGastrointestinal Stromal Tumors Cogent Biosciences, Inc. 51
Early research (Phase 1)Study completedNCT02699515What this trial is testingMSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid TumorsWho this might be right forSolid Tumors Merck KGaA, Darmstadt, Germany 114
Early research (Phase 1)Ended earlyNCT05069935What this trial is testingFT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Fate Therapeutics 16
Early research (Phase 1)Looking for participantsNCT06302621What this trial is testingPemigatinib + Afatinib in Advanced Refractory Solid TumorsWho this might be right forAdvanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+1 more Massachusetts General Hospital 32
Early research (Phase 1)Ended earlyNCT03138538What this trial is testingM8891 First in Human in Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Renal Cell Carcinoma EMD Serono Research & Development Institute, Inc. 27
Early research (Phase 1)Study completedNCT01648764What this trial is testingLY2334737 in Participants With Cancer That is Advanced and/or Has SpreadWho this might be right forMalignant Solid TumorSolid TumorMetastatic Tumor Eli Lilly and Company 73